Literature DB >> 11152386

Comparison of the protection against neuronal injury by hypothalamic peptides and by dexamethasone.

A A Galoyan1, J S Sarkissian, T K Kipriyan, E J Sarkissian, Y K Grigorian, R M Sulkhanyan, T S Khachatrian.   

Abstract

The comparative study has been carried out on hypothalamic neurohormone (proline-rich polypeptides-PRP) and synthetic glucocorticoid dexamethasone (DEX) protective properties at the systemic (i/m) administration. Both background and evoked electrical activity (on n.ischiadicus stimulation) of single neurons in the lumbo-sacral part (laminae II-VI and VII-VIII by Rexed) and field potentials (FP) of spinal cord were recorded during acute experiments on intact spinal rats, subjected to Vipera Raddei (VR) venom intoxication, and chronic spinal cord trauma (hemisection). The action of PRP was characterized by the pronounced activation of the background activity (BA) with adaptive effect, depending on dose and initial level of BA, by results of the statistical analysis. A high effect is received from comparatively small doses. For comparison it was used strong glucocorticoid DEX, possessing single-directed but less expressed excitative action on investigated spinal cord neurons. The initial increase of BA frequency with subsequent depression was the typical symptom of venom influence. A protective effect of preliminary PRP injection is revealed on the succeeding VR venom influence. Use of PRP and DEX causes the increase of reduced activity of neurons on the injury side of animals with spinal cord hemisection. It provides the possibility of the therapeutic utilization. It was revealed considerably more expressed PRP action on neurodegenerative process connected to spinal cord injury (in comparison with DEX). The influence of hormones was compared in identical conditions of experiments on non-injured (control) and injured sides. Taking into consideration revealed protection characteristic of PRP and also the ability of snake venom to stabilize and to prolong its action combined with these preparations, the assumption is made on prospective use of the specified combination in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152386     DOI: 10.1023/a:1026662318816

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Protection against snake venom-induced neuronal injury by the new hypothalamic neurohormone.

Authors:  A A Galoyan; T K Kipriyan; J S Sarkissian; E J Sarkissian; Y K Grigorian; A S Andreasian; E A Chavushyan
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

2.  Estimating stimulus response latency.

Authors:  H S Friedman; C E Priebe
Journal:  J Neurosci Methods       Date:  1998-09-01       Impact factor: 2.390

Review 3.  [Snake venoms as modifying agents of blood coagulation].

Authors:  J Meaume
Journal:  Toxicon       Date:  1966-06       Impact factor: 3.033

4.  Effect of 4-aminopyridine and single-dose methylprednisolone on functional recovery after a chronic spinal cord injury.

Authors:  S S Haghighi; A Clapper; G C Johnson; A Stevens; A Prapaisilp
Journal:  Spinal Cord       Date:  1998-01       Impact factor: 2.772

5.  Protective effect of methylprednisolone on vascular injury in rat spinal cord injury.

Authors:  J Xu; Z X Qu; E L Hogan; P L Perot
Journal:  J Neurotrauma       Date:  1992       Impact factor: 5.269

6.  Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels.

Authors:  M Garcia-Calvo; R J Leonard; J Novick; S P Stevens; W Schmalhofer; G J Kaczorowski; M L Garcia
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

7.  The cardiovascular, coagulation and haematological effects of tiger snake (Notechis scutatus) prothrombin activator and investigation of release of vasoactive substances.

Authors:  J Tibballs
Journal:  Anaesth Intensive Care       Date:  1998-10       Impact factor: 1.669

8.  Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale.

Authors:  E D Hall; J M Braughler
Journal:  Surg Neurol       Date:  1982-11

9.  Dexamethasone directly inhibits snake venom phospholipase A.

Authors:  N Kato; K M Halprin; S Matsuo; J R Taylor
Journal:  Biochem Biophys Res Commun       Date:  1985-07-31       Impact factor: 3.575

10.  Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.

Authors:  C S Lin; R C Boltz; J T Blake; M Nguyen; A Talento; P A Fischer; M S Springer; N H Sigal; R S Slaughter; M L Garcia
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  11 in total

1.  Protective effect of a new hypothalamic peptide against cobra venom and trauma-induced neuronal injury.

Authors:  A A Galoyan; J S Sarkissian; T K Kipriyan; E J Sarkissian; E A Chavushyan; R M Sulkhanyan; I B Meliksetyan; S S Abrahamyan; Z A Avetisyan; N A Otieva
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Effect of hypothalamic proline-rich-polypeptide on voltage-gated Ca2+ currents in retinal ganglion cells.

Authors:  Abram Akopian; Armen Galoyan
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

3.  Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Authors:  Armen A Galoyan; John S Sarkissian; Vergine A Chavushyan; Ruben M Sulkhanyan; Zaruhi E Avakyan; Zubeida A Avetisyan; Yuri Kh Grigorian; Davit O Abrahamyan
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

4.  The protective effect of vipera raddei venom on peripheral nerve damage.

Authors:  V A Chavushyan; A Zh Gevorkyan; Z E Avakyan; Z A Avetisyan; M V Pogosyan; Dzh S Sarkisyan
Journal:  Neurosci Behav Physiol       Date:  2006-01

5.  Effect of hypothalamic proline-rich peptide (PRP-1) on neuronal and bone marrow cell apoptosis.

Authors:  Armen A Galoyan; Josef Krieglstein; Susanne Klumpp; Kristina E Danielian; Karine A Galoian; Wolfram Kremers; Kristina B Bezirganyan; Tigran K Davtyan
Journal:  Neurochem Res       Date:  2007-06-05       Impact factor: 3.996

6.  Hypothalamic proline rich polypeptide regulates hematopoiesis.

Authors:  Kristina B Bezirganyan; Tigran K Davtyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2009-12-18       Impact factor: 3.996

7.  A new hypothalamic polypeptide is a regulator of myelopoiesis.

Authors:  Armen A Galoyan; Vardan S Aprikyan
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

8.  PRP-1 protective effect against central and peripheral neurodegeneration following n. ischiadicus transection.

Authors:  Armen A Galoyan; John S Sarkissian; Ruben M Sulkhanyan; Vergine A Chavushyan; Zubeida A Avetisyan; Zaruhi E Avakyan; Anoush J Gevorgyan; Davit O Abrahamyan; Yuri Kh Grigorian
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

9.  Proline-rich polypeptide-1 protects the cells in vitro from genotoxic effects of mitomycin C.

Authors:  R M Aroutiounian; G G Hovhannisyan; G H Gasparyan; K S Margaryan; D N Aroutiounian; N K Sarkissyan; A A Galoyan
Journal:  Neurochem Res       Date:  2009-12-01       Impact factor: 3.996

10.  Survival of trauma-injured neurons in rat brain by treatment with proline-rich peptide (PRP-1): an immunohistochemical study.

Authors:  Silva S Abrahamyan; John S Sarkissian; Irina B Meliksetyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.